Summary

Laboratory Corporation of America Holdings (LabCorp) is an independent clinical laboratory company engaged in developing and commercializing a wide range of new diagnostic technologies and testing services. The company divides its products into two reportable segments namely the Clinical diagnostics laboratory segment , which includes core testing as well as genomic and esoteric testing, and Others, which includes the Company’s non-U.S. clinical diagnostic laboratory operations in Ontario. LabCorp offers services such as general and specialty laboratory testing, ambulatory monitoring services, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, DNA identification services, forensic identity services, health care provider services, insurance health plan services, paternity testing services, patient services, personalized medicine and hospital services. The company has a network of branches along with 44 primary laboratories and more than 1700 patient service centers. The major clients of the company are managed care organizations, physicians, hospitals, government agencies and biotechnology and pharmaceutical companies spread across all the 50 states in the US, the District of Columbia, Belgium, Puerto Rico, Japan, China, Singapore, the UK and three Canadian provinces. LabCorp is headquartered in Burlington, North Carolina, the US.

The company focuses on expanding its service portfolio through both inorganic and organic approaches. The inorganic approach includes acquisitions which can be reflected from the recent acquisition of MEDTOX Scientific, Inc. The organic approach includes in-house development of several testing technologies. These concentrated efforts will enable the company gain more market share along with better catering of clients.

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2009 to YTD 2015 7
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2009 to YTD 2015 8
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2009 to YTD 2015 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2009 to YTD 2015 10
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2009 to YTD 2015 11
Laboratory Corporation of America Holdings, Medical Equipment, Deal Details 15
Venture Financing 15
Vivify Health Raises Funds in Series B Venture Financing 15
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 16
Flatiron Health Raises US$130 Million In Series B Financing 18
Flatiron Health Raises US$8 Million In Series A Financing 20
Nodality Secures US$15.5 Million In Financing Round 22
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 24
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 26
Partnerships 28
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 28
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 29
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 30
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 31
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 32
Orchid Cellmark Enters Into Worldwide Licensing Agreement With Illumina 34
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 35
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 36
Emdeon Enters Into Strategic Alliance With LabCorp 37
Duke University Medical Center Enters Into Joint Venture With LabCorp 38
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 39
Monogram Biosciences Extends An Agreement With Pfizer 40
University of Minnesota Signs Licensing Agreement With LabCorp 41
Debt Offering 42
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 42
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 44
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 46
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 48
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 50
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 52
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 54
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 56
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 58
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 60
Asset Transactions 62
Marken Acquires European Kit Building Operation Facility From LabCorp 62
DNA Diagnostics Center Acquires Government Paternity Business From Orchid Cellmark 63
Acquisition 64
LabCorp Acquires Bode Technology from SolutionPoint 64
LabCorp Acquires LipoScience for USD85.3 Million 65
LabCorp to Acquire Covance for USD6.1 Billion 67
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 70
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 71
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 73
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 74
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 77
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 79
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 80
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 81
Lab Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 82
Laboratory Corporation of America Holdings - Key Competitors 84
Key Employees 85
Locations And Subsidiaries 86
Head Office 86
Other Locations and Subsidiaries 86
Appendix 90
Methodology 90
About GlobalData 90
Contact Us 90
Disclaimer 90

List of Tables

Laboratory Corporation of America Holdings, Medical Equipment, Key Facts, 2013 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2009 to YTD 2015 7
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2009 to YTD 2015 8
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2009 to YTD 2015 9
Laboratory Corporation of America Holdings, Deals By Market, 2009 to YTD 2015 10
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2009 to YTD 2015 11
Vivify Health Raises Funds in Series B Venture Financing 15
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 16
Flatiron Health Raises US$130 Million In Series B Financing 18
Flatiron Health Raises US$8 Million In Series A Financing 20
Nodality Secures US$15.5 Million In Financing Round 22
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 24
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 26
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 28
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 29
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 30
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 31
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 32
Orchid Cellmark Enters Into Worldwide Licensing Agreement With Illumina 34
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 35
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 36
Emdeon Enters Into Strategic Alliance With LabCorp 37
Duke University Medical Center Enters Into Joint Venture With LabCorp 38
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 39
Monogram Biosciences Extends An Agreement With Pfizer 40
University of Minnesota Signs Licensing Agreement With LabCorp 41
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 42
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 44
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 46
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 48
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 50
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 52
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 54
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 56
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 58
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 60
Marken Acquires European Kit Building Operation Facility From LabCorp 62
DNA Diagnostics Center Acquires Government Paternity Business From Orchid Cellmark 63
LabCorp Acquires Bode Technology from SolutionPoint 64
LabCorp Acquires LipoScience for USD85.3 Million 65
LabCorp to Acquire Covance for USD6.1 Billion 67
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 70
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 71
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 73
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 74
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 77
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 79
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 80
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 81
Lab Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 82
Laboratory Corporation of America Holdings, Key Competitors 84
Laboratory Corporation of America Holdings, Key Employees 85
Laboratory Corporation of America Holdings, Other Locations 86
Laboratory Corporation of America Holdings, Subsidiaries 88

List of Figures

Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2009 to YTD 2015 7
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2009 to YTD 2015 8
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2009 to YTD 2015 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Market, 2009 to YTD 2015 10

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Bearing Markets in the World to 2019 - Market Size, Development, and Forecasts

Bearing Markets in the World to 2019 - Market Size, Development, and Forecasts

  • $ 18 208
  • Industry report
  • April 2015
  • by Global Research & Data Services Oy

The expansion of the global bearing industry is forecast to reach 2.0% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 5.8%. Currently, ball bearings ...

Opportunity in the Indian Life Science Industry - 2015 ; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Life Science Industry - 2015 ; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 12 000
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Opportunity in the Indian Life Science Industry current scenario, structure and practices. In depth Healthcare market scenario includes; a.Healthcare Market - 2011 ...

Europe Markets for Infusion Therapy Devices

Europe Markets for Infusion Therapy Devices

  • $ 10 995
  • Industry report
  • April 2015
  • by iData Research, Inc.

In 2014, the market for infusion therapy devices included infusion pumps, intravenous (IV) sets and needleless connectors (NLCs). These three broad categories are further segmented based on specific distinguishing ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.